Cargando…

Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study

BACKGROUND: Frameless immobilization allows for planning and quality assurance of intensity-modulated radiosurgery (IM-SRS) plans. We tested the hypothesis that IM-SRS planning with uniform tissue density corrections results in dose inaccuracy compared to heterogeneity-corrected algorithms. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Lisa B. E., Bond, Cindy, Odom, Aaron, Sun, David A., Spalding, Aaron C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574166/
https://www.ncbi.nlm.nih.gov/pubmed/26377815
http://dx.doi.org/10.1186/s13014-015-0500-y
_version_ 1782390583288922112
author Shields, Lisa B. E.
Bond, Cindy
Odom, Aaron
Sun, David A.
Spalding, Aaron C.
author_facet Shields, Lisa B. E.
Bond, Cindy
Odom, Aaron
Sun, David A.
Spalding, Aaron C.
author_sort Shields, Lisa B. E.
collection PubMed
description BACKGROUND: Frameless immobilization allows for planning and quality assurance of intensity-modulated radiosurgery (IM-SRS) plans. We tested the hypothesis that IM-SRS planning with uniform tissue density corrections results in dose inaccuracy compared to heterogeneity-corrected algorithms. METHODS: Fifteen patients with tumors of the pituitary or cavernous sinus underwent frameless IM-SRS. Treatment planning CT and MRI scans were obtained and fused to delineate the tumor, optic nerves, chiasm, and brainstem. The plan was developed with static gantry IM-SRS fields using a pencil beam (PB), analytical anisotropic (AAA), and Acuros XB (AXB) algorithms. We evaluated measures of target coverage as well as doses to organs at risk (OAR) for each algorithm. We compared the results of each algorithm in the cases where PTV overlapped OAR (n = 10) to cases without overlapping OAR with PTV (n = 5). Utilizing film dosimetry, we measured the dose distribution for each algorithm through a uniform density target to a rando phantom with non-uniform density of air, tissue, and bone. RESULTS: There was no difference in target coverage measured by D(MaxPTV), D(MinPTV), D(95%PTV), or the isodose surface (IDS) covering 95 % of the PTV regardless of algorithm. However, there were differences in dose to OAR. PB predicted higher (p < 0.05) Dmax for the brainstem, chiasm, right optic nerve, and left optic nerve. In cases of PTV overlapping an optic nerve (n = 7), PB was unable to limit dose to 8Gy while achieving PTV coverage (PB 855 cGy vs. AAA 769 cGy, p = 0.05 vs. AXB 658 cGy, p = 0.03). Within the rando phantom, the PB and AAA algorithms over-estimated the dose delivered in the bone-tissue-air interface of the sinus (+17 %), while the AXB algorithm closely predicted the actual dose delivered through the inhomogeneous tissue (+/- 1 % max, p < 0.05). CONCLUSIONS: Patients undergoing frameless SRS benefit from heterogeneity corrected dose plans when the lesion lies in areas of widely varying tissue density and near critical normal structures such as the skull base. Film dosimetry confirms that the AXB dose calculation algorithm more accurately predicts actual dose delivered though tissues of varying densities than PB or AAA dose calculation algorithms.
format Online
Article
Text
id pubmed-4574166
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45741662015-09-19 Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study Shields, Lisa B. E. Bond, Cindy Odom, Aaron Sun, David A. Spalding, Aaron C. Radiat Oncol Research BACKGROUND: Frameless immobilization allows for planning and quality assurance of intensity-modulated radiosurgery (IM-SRS) plans. We tested the hypothesis that IM-SRS planning with uniform tissue density corrections results in dose inaccuracy compared to heterogeneity-corrected algorithms. METHODS: Fifteen patients with tumors of the pituitary or cavernous sinus underwent frameless IM-SRS. Treatment planning CT and MRI scans were obtained and fused to delineate the tumor, optic nerves, chiasm, and brainstem. The plan was developed with static gantry IM-SRS fields using a pencil beam (PB), analytical anisotropic (AAA), and Acuros XB (AXB) algorithms. We evaluated measures of target coverage as well as doses to organs at risk (OAR) for each algorithm. We compared the results of each algorithm in the cases where PTV overlapped OAR (n = 10) to cases without overlapping OAR with PTV (n = 5). Utilizing film dosimetry, we measured the dose distribution for each algorithm through a uniform density target to a rando phantom with non-uniform density of air, tissue, and bone. RESULTS: There was no difference in target coverage measured by D(MaxPTV), D(MinPTV), D(95%PTV), or the isodose surface (IDS) covering 95 % of the PTV regardless of algorithm. However, there were differences in dose to OAR. PB predicted higher (p < 0.05) Dmax for the brainstem, chiasm, right optic nerve, and left optic nerve. In cases of PTV overlapping an optic nerve (n = 7), PB was unable to limit dose to 8Gy while achieving PTV coverage (PB 855 cGy vs. AAA 769 cGy, p = 0.05 vs. AXB 658 cGy, p = 0.03). Within the rando phantom, the PB and AAA algorithms over-estimated the dose delivered in the bone-tissue-air interface of the sinus (+17 %), while the AXB algorithm closely predicted the actual dose delivered through the inhomogeneous tissue (+/- 1 % max, p < 0.05). CONCLUSIONS: Patients undergoing frameless SRS benefit from heterogeneity corrected dose plans when the lesion lies in areas of widely varying tissue density and near critical normal structures such as the skull base. Film dosimetry confirms that the AXB dose calculation algorithm more accurately predicts actual dose delivered though tissues of varying densities than PB or AAA dose calculation algorithms. BioMed Central 2015-09-17 /pmc/articles/PMC4574166/ /pubmed/26377815 http://dx.doi.org/10.1186/s13014-015-0500-y Text en © Shields et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Shields, Lisa B. E.
Bond, Cindy
Odom, Aaron
Sun, David A.
Spalding, Aaron C.
Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study
title Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study
title_full Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study
title_fullStr Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study
title_full_unstemmed Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study
title_short Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study
title_sort heterogeneity correction for intensity-modulated frameless srs in pituitary and cavernous sinus tumors: a retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574166/
https://www.ncbi.nlm.nih.gov/pubmed/26377815
http://dx.doi.org/10.1186/s13014-015-0500-y
work_keys_str_mv AT shieldslisabe heterogeneitycorrectionforintensitymodulatedframelesssrsinpituitaryandcavernoussinustumorsaretrospectivestudy
AT bondcindy heterogeneitycorrectionforintensitymodulatedframelesssrsinpituitaryandcavernoussinustumorsaretrospectivestudy
AT odomaaron heterogeneitycorrectionforintensitymodulatedframelesssrsinpituitaryandcavernoussinustumorsaretrospectivestudy
AT sundavida heterogeneitycorrectionforintensitymodulatedframelesssrsinpituitaryandcavernoussinustumorsaretrospectivestudy
AT spaldingaaronc heterogeneitycorrectionforintensitymodulatedframelesssrsinpituitaryandcavernoussinustumorsaretrospectivestudy